Sierra Oncology board member to resign
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Sierra Oncology, previously known as ProNAi Therapeutics Inc., said in a Form 8-K filing that James Topper will leave the board April 10.
Daniel Estes will replace Topper as a director while Donald Parfet will take over Topper's duties as the chair of the nominating and corporate governance committee on an interim basis.
